The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Porcine Circovirus Vaccine-Global Market Insights and Sales Trends 2024

Porcine Circovirus Vaccine-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1838347

No of Pages : 109

Synopsis
Porcine circovirus (PCV) is a group of single-stranded DNA viruses (class II), that is nonenveloped with an unsegmented circular genome.
The global Porcine Circovirus Vaccine market size is expected to reach US$ 409 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Porcine Circovirus Vaccine in various end use industries. The expanding demands from the Piglets and Adults Pigs, are propelling Porcine Circovirus Vaccine market. Genetic Engineering Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Porcine Circovirus Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Porcine Circovirus Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Porcine Circovirus Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Porcine Circovirus Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Porcine Circovirus Vaccine covered in this report include Chopper Biology, ChengDu Tecbond, Ringpu Biology, Qilu Animal, DHN, CAVAC, Komipharm, Jinyu Bio-Technology and Zoetis, etc.
The global Porcine Circovirus Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chopper Biology
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Global Porcine Circovirus Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Porcine Circovirus Vaccine market, Segment by Type:
Genetic Engineering Vaccine
Killed Vaccines
Global Porcine Circovirus Vaccine market, by Application
Piglets
Adults Pigs
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Porcine Circovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Porcine Circovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Porcine Circovirus Vaccine Market Overview
1.1 Porcine Circovirus Vaccine Product Overview
1.2 Porcine Circovirus Vaccine Market Segment by Type
1.2.1 Genetic Engineering Vaccine
1.2.2 Killed Vaccines
1.3 Global Porcine Circovirus Vaccine Market Size by Type
1.3.1 Global Porcine Circovirus Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Porcine Circovirus Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Porcine Circovirus Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Porcine Circovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Porcine Circovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Porcine Circovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Porcine Circovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Porcine Circovirus Vaccine Sales Breakdown by Type (2018-2023)
2 Global Porcine Circovirus Vaccine Market Competition by Company
2.1 Global Top Players by Porcine Circovirus Vaccine Sales (2018-2023)
2.2 Global Top Players by Porcine Circovirus Vaccine Revenue (2018-2023)
2.3 Global Top Players by Porcine Circovirus Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Porcine Circovirus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Porcine Circovirus Vaccine Market Competitive Situation and Trends
2.5.1 Porcine Circovirus Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Porcine Circovirus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Porcine Circovirus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Porcine Circovirus Vaccine Market
2.8 Key Manufacturers Porcine Circovirus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Porcine Circovirus Vaccine Status and Outlook by Region
3.1 Global Porcine Circovirus Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Porcine Circovirus Vaccine Historic Market Size by Region
3.2.1 Global Porcine Circovirus Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Porcine Circovirus Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Porcine Circovirus Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Porcine Circovirus Vaccine Forecasted Market Size by Region
3.3.1 Global Porcine Circovirus Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Porcine Circovirus Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Porcine Circovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Porcine Circovirus Vaccine by Application
4.1 Porcine Circovirus Vaccine Market Segment by Application
4.1.1 Piglets
4.1.2 Adults Pigs
4.2 Global Porcine Circovirus Vaccine Market Size by Application
4.2.1 Global Porcine Circovirus Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Porcine Circovirus Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Porcine Circovirus Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Porcine Circovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Porcine Circovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Porcine Circovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Porcine Circovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Porcine Circovirus Vaccine Sales Breakdown by Application (2018-2023)
5 North America Porcine Circovirus Vaccine by Country
5.1 North America Porcine Circovirus Vaccine Historic Market Size by Country
5.1.1 North America Porcine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Porcine Circovirus Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Porcine Circovirus Vaccine Sales in Value by Country (2018-2023)
5.2 North America Porcine Circovirus Vaccine Forecasted Market Size by Country
5.2.1 North America Porcine Circovirus Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Porcine Circovirus Vaccine Sales in Value by Country (2024-2029)
6 Europe Porcine Circovirus Vaccine by Country
6.1 Europe Porcine Circovirus Vaccine Historic Market Size by Country
6.1.1 Europe Porcine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Porcine Circovirus Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Porcine Circovirus Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Porcine Circovirus Vaccine Forecasted Market Size by Country
6.2.1 Europe Porcine Circovirus Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Porcine Circovirus Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Porcine Circovirus Vaccine by Region
7.1 Asia-Pacific Porcine Circovirus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Porcine Circovirus Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Porcine Circovirus Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Porcine Circovirus Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Porcine Circovirus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Porcine Circovirus Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Porcine Circovirus Vaccine Sales in Value by Region (2024-2029)
8 Latin America Porcine Circovirus Vaccine by Country
8.1 Latin America Porcine Circovirus Vaccine Historic Market Size by Country
8.1.1 Latin America Porcine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Porcine Circovirus Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Porcine Circovirus Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Porcine Circovirus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Porcine Circovirus Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Porcine Circovirus Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Porcine Circovirus Vaccine by Country
9.1 Middle East and Africa Porcine Circovirus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Porcine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Porcine Circovirus Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Porcine Circovirus Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Porcine Circovirus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Porcine Circovirus Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Porcine Circovirus Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Chopper Biology
10.1.1 Chopper Biology Company Information
10.1.2 Chopper Biology Introduction and Business Overview
10.1.3 Chopper Biology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Chopper Biology Porcine Circovirus Vaccine Products Offered
10.1.5 Chopper Biology Recent Development
10.2 ChengDu Tecbond
10.2.1 ChengDu Tecbond Company Information
10.2.2 ChengDu Tecbond Introduction and Business Overview
10.2.3 ChengDu Tecbond Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ChengDu Tecbond Porcine Circovirus Vaccine Products Offered
10.2.5 ChengDu Tecbond Recent Development
10.3 Ringpu Biology
10.3.1 Ringpu Biology Company Information
10.3.2 Ringpu Biology Introduction and Business Overview
10.3.3 Ringpu Biology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ringpu Biology Porcine Circovirus Vaccine Products Offered
10.3.5 Ringpu Biology Recent Development
10.4 Qilu Animal
10.4.1 Qilu Animal Company Information
10.4.2 Qilu Animal Introduction and Business Overview
10.4.3 Qilu Animal Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Qilu Animal Porcine Circovirus Vaccine Products Offered
10.4.5 Qilu Animal Recent Development
10.5 DHN
10.5.1 DHN Company Information
10.5.2 DHN Introduction and Business Overview
10.5.3 DHN Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 DHN Porcine Circovirus Vaccine Products Offered
10.5.5 DHN Recent Development
10.6 CAVAC
10.6.1 CAVAC Company Information
10.6.2 CAVAC Introduction and Business Overview
10.6.3 CAVAC Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 CAVAC Porcine Circovirus Vaccine Products Offered
10.6.5 CAVAC Recent Development
10.7 Komipharm
10.7.1 Komipharm Company Information
10.7.2 Komipharm Introduction and Business Overview
10.7.3 Komipharm Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Komipharm Porcine Circovirus Vaccine Products Offered
10.7.5 Komipharm Recent Development
10.8 Jinyu Bio-Technology
10.8.1 Jinyu Bio-Technology Company Information
10.8.2 Jinyu Bio-Technology Introduction and Business Overview
10.8.3 Jinyu Bio-Technology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Jinyu Bio-Technology Porcine Circovirus Vaccine Products Offered
10.8.5 Jinyu Bio-Technology Recent Development
10.9 Zoetis
10.9.1 Zoetis Company Information
10.9.2 Zoetis Introduction and Business Overview
10.9.3 Zoetis Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Zoetis Porcine Circovirus Vaccine Products Offered
10.9.5 Zoetis Recent Development
10.10 Boehringer Ingelheim
10.10.1 Boehringer Ingelheim Company Information
10.10.2 Boehringer Ingelheim Introduction and Business Overview
10.10.3 Boehringer Ingelheim Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Boehringer Ingelheim Porcine Circovirus Vaccine Products Offered
10.10.5 Boehringer Ingelheim Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Porcine Circovirus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Porcine Circovirus Vaccine Industrial Chain Analysis
11.4 Porcine Circovirus Vaccine Market Dynamics
11.4.1 Porcine Circovirus Vaccine Industry Trends
11.4.2 Porcine Circovirus Vaccine Market Drivers
11.4.3 Porcine Circovirus Vaccine Market Challenges
11.4.4 Porcine Circovirus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Porcine Circovirus Vaccine Distributors
12.3 Porcine Circovirus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’